HPPI Financials 07/16/2014 06:01:48 HedgePath Pha

HPPI Financials 07/16/2014 06:01:48
HedgePath Pharmaceuticals, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 1,065 - - -
Sales, General and Admin. 935 561 982 1,026
Non-Recurring Items - - - -
Other - - - -
Operating Income (2,000) (561) (982) (1,026)
Income From Continuing Operations
Add'l Income/Expense Items 167 747 935 615
Earnings Before Interest and Tax (1,833) (480) (47) (411)
Interest Expense 2 - 218 233
Earnings Before Tax (1,835) (480) (265) (645)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (1,835) 186 (265) (645)
Non Recurring Events
Discontinued Operations - - 37 (360)
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,835) 186 (228) (1,004)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (1,835) 186 (228) (1,004)